Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Pfizer
 More »

  • Novo Nordisk Reports Promising Phase III Results for Hemophilia...
    scale production of the recombinant Factor IX. Novo Nordisk hopes to challenge Pfizer, whose BeneFIX® is the first recombinant Factor IX product marketed for people with ...
    5-17-2013
  • Moving Genomics Closer to the Clinic
    ... Several tests are available that analyze tumors for single or several genetic anomalies. One test, developed by Abbott Laboratories in collaboration with Pfizer, identifies ...
    5-15-2013
  • Biotechs Need to Walk the Walk on Drug Value
    Idec, EMD Serono, Janssen, Merck & Co., Pfizer, and Sunovion Pharmaceuticals to form the ... Johnson & Johnson, Lilly, Pfizer, Roche, and Sanofi-created TransCelerate ...
    5-15-2013
  • Layoffs Imminent at Astellas: Two U.S. Labs to Close
    ... Astellas follows other pharma giants that have shrunk their R&D operations in recent years-a category that includes AstraZeneca, Roche, Pfizer, and Takeda-as companies scramble to ...
    5-14-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Financial terms not disclosed. Agilent Technologies (Dako) and Pfizer Agreement announced ... Financial terms not disclosed. Roche (Ventana Medical Systems), Pfizer, and Cell Signaling ...
    5-9-2013
  • Another Alzheimer's Drug Fails Phase III Trial
    ... Also last year, Johnson & Johnson's Janssen Alzheimer Immunotherapy unit and Pfizer ended ... J&J took a $700 million in-process R&D charge in Q3 2012. And early in 2012, Pfizer wrote ...
    5-7-2013
  • Merck Launches Up To $430M Diabetes Collaboration with Abide
    ... On Monday, the company announced a collaboration with Pfizer to commercialize its ... Merck agreed to pay Pfizer up to $60 million in undisclosed upfront and milestone ...
    5-2-2013
  • Merck Joins Pfizer to Develop Type 2 Diabetes Drug
    On the eve of Phase III trials expected to start later this year, Merck & Co. and Pfizer ... Merck has agreed to pay Pfizer up to $60 million in undisclosed up-front and milestone ...
    4-29-2013
  • GEN | Biolinks
    ... BV PEPTONIC Medical AB Pergamum AB Perkin Elmer Pfenex Pfenex Inc Pfizer Inc Pharma Industry Finland - PIF pharmaCline PharmAthene, Inc PhaseBio Pharmaceuticals, Inc Phigenix, Inc. ...
  • Pfizer, Alberta Renew Funding for Translational Research
    Pfizer and the provincial government of Alberta, Canada, said yesterday they will renew their support for the two-year-old Alberta-Pfizer Translational Research Collaboration, a ...
    4-25-2013
  • E&Y: Biotechs Must Walk the Walk on Drug Value
    Idec, EMD Serono, Janssen, Merck & Co., Pfizer, and Sunovion Pharmaceuticals to form the ... Johnson & Johnson, Lilly, Pfizer, Roche, and Sanofi-created TransCelerate ...
    4-22-2013
  • AstraZeneca, BIND Enter $200M+ Cancer Nanomedicine Agreement
    The AstraZeneca deal marks BIND's third global partnership with big pharma in four months. Earlier this month , BIND announced a $210 million deal it made with Pfizer to develop ...
    4-22-2013
  • Biosimilars: 10 Drugs to Watch
    ... (includes $4.236 billion Amgen + $3.737 billion Pfizer). Amgen markets Enbrel in U.S. and Canada under an agreement with Pfizer set to expire October 31, 2013 Patent status: ...
    4-22-2013
  • Alzheimer's: Lilly Investment Signals R&D Shift
    ... Solanezumab wasn't the only anti-beta-amyloid monoclonal antibody to fail in Phase III. Johnson & Johnson and Pfizer ended development of bapineuzumab in August after it failed to ...
    4-17-2013
  • People in the News
    He has more than 25 years of experience in the life sciences industry. Most recently, Taylor was vp, global clinical trial management at Pfizer. He also served as global head of ...
    4-15-2013
  • More »

    Journal Articles

  • COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib...
    Melchiorre Cervello, Dimcho Bachvarov, Antonella Cusimano, Francesca Sardina, Antonina Azzolina, Nadia Lampiasi, Lydia Giannitrapani, James A. McCubrey, Giuseppe Montalto
    OMICS: A Journal of Integrative Biology
    COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells OMICS: A Journal of Integrative Biology Abstract Celecoxib (Celebrex(R), Pfizer) is a ...
  • Case Report: Association of Combined Nonarteritic Anterior Ischemic...
    Raj Akash, Das Hrishikesh, Paul Amith, Stafanous Sabah
    Journal of Ocular Pharmacology and Therapeutics
    and cilioretinal artery occlusion resulting from misuse of sildenafil citrate (Viagra ®; Pfizer Pharmaceuticals, New York, NY). Design: This is an observational case report. ...
  • Successful Use of Vaginal Sildenafil Citrate in Two Infertility...
    Michael Zinger, James H. Liu, Michael A. Thomas
    Journal of Women's Health
    Successful Use of Vaginal Sildenafil Citrate in Two Infertility Patients with Asherman's Syndrome Journal of Women's Health Vaginal sildenafil citrate (Viagra, Pfizer, Inc., New ...
  • Trough Insulin Levels in Bronchoalveolar Lavage Following Inhaled...
    Carlos O. Mendivil, John G. Teeter, Gregory L. Finch, Pamela F. Schwartz, Richard J. Riese, Joseph D. Brain
    Diabetes Technology & Therapeutics
    We examined the disposition of inhaled human insulin (Exubera® [EXU] human insulin [recombinant DNA origin], Pfizer, New York, NY) in the lungs by measuring trough insulin levels ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll